SCHEMBL5335310

SCHEMBL5335310

CCOCC(=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27524931 0.78
Potassium Ion SCHEMBL25270213 0.78 ALDH1A1 (0.37)
SCHEMBL5993777 0.77 ALDH1A1 (0.42)
SCHEMBL48574 0.77
Oxalic Acid SCHEMBL5756637 0.76 ALDH1A1 (0.43)
SCHEMBL2769593 0.74
SCHEMBL2771734 0.74
SCHEMBL8557665 0.74
SCHEMBL2770312 0.74
SCHEMBL295324 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021049-A1 Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related Compounds ILYPSA, INC. 2008-01-24 US disclosed
EP-1797219-A2 PAINT&amp;INK REMOVER TWO-PHASE SYSTEM CHURCH &amp; DWIGHT COMPANY, INC. (US) 2007-06-20 EP disclosed
US-20070135383-A1 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors ILYPSA, INC. 2007-06-14 US disclosed
WO-2006031914-A2 PAINT &amp; INK REMOVER TWO-PHASE SYSTEM CHURCH & DWIGHT CO., INC. (US) 2006-03-23 WO disclosed